A Prospective, Multicenter, Randomized Phase III Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Ifosfamide; Methotrexate; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 11 Dec 2015 Biomarkers information updated
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 04 Jun 2013 Status changed from recruiting to completed.